Form 4: SVP at Soleno Therapeutics Sells Shares to Cover Tax Obligations
SEC Form 4
Kristen Yen, a Senior Vice President at Soleno Therapeutics, sold shares of common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Summary
- On August 5th and 6th, 2024, Kristen Yen, Senior Vice President, Clinical Operations at Soleno Therapeutics, sold shares of the company's common stock.
- The sales were executed in multiple transactions at varying prices.
- The sales were conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- After these transactions, Yen still beneficially owns a significant number of Soleno Therapeutics' common stock shares.
Sentiment
Score: 5
Explanation: This is a neutral event. The sale of shares to cover tax obligations is a common practice and doesn't necessarily reflect a negative outlook on the company.
Industry Context
Form 4 filings are a routine part of the stock market, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The stock sale by a company insider could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 08/05/2024 | Kristen Yen sold 2,826 shares of Soleno Therapeutics common stock at a weighted average price of $45.4767 and 2,191 shares at a weighted average price of $46.1439. |
| 08/06/2024 | Kristen Yen sold 585 shares of Soleno Therapeutics common stock at a weighted average price of $43.6397, 1,976 shares at a weighted average price of $45.2471, and 3,396 shares at a weighted average price of $45.89. |
| 08/07/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.